BENTONVILLE, October 21, 2025 – Walmart (WMT.N) will become the first U.S. retailer to sell Abbott Laboratories’ (ABT.N) over-the-counter continuous glucose monitor in physical stores.
The move expands access to Abbott’s Lingo device beyond online-only sales, potentially driving revenue growth for both companies in the expanding consumer health monitoring market.
- Walmart launches Abbott Lingo across 3,500+ U.S. stores nationwide
- Two-week sensor pack priced at 48.97 per unit
- First physical retail availability for over-the-counter glucose monitors
Market Context and Expansion
Abbott’s Lingo device was previously available only through HelloLingo.com and Amazon’s online platform 1. The retail giant will roll out the two-week sensor pack across more than 3,500 physical locations and online at 48.97 per single unit 2.
This partnership represents a significant expansion in the consumer glucose monitoring market, which has traditionally required prescriptions for continuous monitoring devices. The over-the-counter availability targets health-conscious consumers seeking metabolic insights without diabetes diagnoses.
Strategic Implications
Walmart’s pharmacy and health services division continues expanding its healthcare footprint through partnerships with medical device manufacturers. The retailer has invested heavily in health services, including primary care clinics and specialty pharmacy services.
For Abbott, the Walmart partnership provides substantial physical distribution beyond digital channels. The medical device company has been diversifying its consumer health portfolio while maintaining its position in traditional medical diagnostics.
Product Positioning
The Lingo system allows users to monitor glucose levels continuously without finger-stick testing, appealing to fitness enthusiasts and pre-diabetic individuals. Unlike prescription continuous glucose monitors designed for diabetes management, Lingo targets broader wellness applications.
The 48.97 price point positions the product competitively in the consumer health technology market. Users can track glucose responses to food, exercise, and sleep patterns through a smartphone application.
Industry Impact
This launch signals growing mainstream adoption of continuous glucose monitoring technology beyond diabetes management. The partnership could encourage other retailers to pursue similar health technology offerings in physical stores.
The move aligns with broader consumer trends toward proactive health monitoring and data-driven wellness decisions. Walmart’s extensive store network provides Abbott with unparalleled distribution reach across diverse demographics and geographic markets.
Not investment advice. For informational purposes only.
References
1(October 21, 2025). “Walmart to be first US retailer to sell Abbott’s continuous glucose monitor”. Reuters. Retrieved October 21, 2025.
2(October 21, 2025). “Walmart to sell Abbott’s glucose monitor in US retail first”. Seeking Alpha. Retrieved October 21, 2025.
3(October 21, 2025). “Walmart to sell Abbott Lingo OTC glucose monitor in retail first”. Axios. Retrieved October 21, 2025.
4(October 21, 2025). “Walmart to be first US retailer to sell Abbott’s continuous glucose monitor”. KFGO. Retrieved October 21, 2025.